Aquilo Capital Management, LLC

Overview

• HeadquartersSan Francisco, United States²
• Legal formLimited Liability Company²
• LEI254900J03UBQSFDMNU40²
• StatusActive²
• LEI statusLapsed (not renewed)²
• Registered addressC/O MARC SCHNEIDMAN, 94129 San Francisco, United States²
• Registered withSecretary of State, 201003310148²

See how the biggest companies compare on our leaderboards

Corporate structure

Aquilo Capital Management, LLC sits at the top of its group. 6 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); stakes of 5% or more it reported on Schedules 13D and 13G (4 companies). Each entity in the chart links to its source.

Timeline

1. Jan 29, 2010Founded Aquilo Capital Management, LLC is founded²

Filings

19 filings to the SEC since October 2021: 19 other. The latest 19:

1. Nov 12, 202513F-HR EDGAR
2. Aug 22, 2025N-PX EDGAR
3. Aug 6, 202513F-HR EDGAR
4. May 15, 202513F-HR EDGAR
5. Feb 14, 202513F-HR EDGAR
6. Nov 14, 202413F-HR EDGAR
7. Aug 29, 2024N-PX EDGAR
8. Aug 14, 202413F-HR EDGAR
9. May 15, 202413F-HR EDGAR
10. Feb 14, 202413F-HR EDGAR
11. Nov 14, 202313F-HR EDGAR
12. Aug 14, 202313F-HR EDGAR
13. May 15, 202313F-HR EDGAR
14. Feb 14, 202313F-HR EDGAR
15. Nov 14, 202213F-HR EDGAR
16. Aug 15, 202213F-HR EDGAR
17. May 16, 202213F-HR EDGAR
18. Feb 14, 202213F-HR EDGAR
19. Nov 15, 202113F-HR EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Stakes it holds

Aquilo Capital Management, LLC has told the SEC it owns more than 5% of 4 companies, latest first (Schedules 13D and 13G).

• Precision BioSciencesSCHEDULE 13G/A Mar 18, 2024 to Aug 6, 2025³
• PALVELLA THERAPEUTICS, INC.SC 13G/A Feb 14, 2022 to Feb 14, 2024⁴
• Magenta TherapeuticsSC 13G/A Feb 14, 2022 to Feb 14, 2023⁵
• Spero Therapeutics, Inc.SC 13G/A Feb 14, 2022 to Feb 14, 2023⁶